SCM
NVCR icon

Schnieders Capital Management’s NovoCure NVCR Stock Holding History

Schnieders Capital Management’s Portfolio NVCR Stock Details NVCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-2,757
Closed -$320K – 204
2021
Q3 		$320K Sell
2,757
-815
-23% -$123K 0.09% 148
2021
Q2 		$792K Sell
3,572
-25
-0.7% -$4.86K 0.22% 85
2021
Q1 		$476K Sell
3,597
-985
-21% -$156K 0.14% 113
2020
Q4 		$793K Sell
4,582
-450
-9% -$61.6K 0.26% 74
2020
Q3 		$560K Buy
5,032
+800
+19% +$64K 0.21% 82
2020
Q2 		$251K Sell
4,232
-1,200
-22% -$78.9K 0.1% 142
2020
Q1 		$366K Buy
5,432
+400
+8% +$31.6K 0.18% 98
2019
Q4 		$424K Buy
5,032
+200
+4% +$16.1K 0.15% 109
2019
Q3 		$361K Sell
4,832
-2,425
-33% -$194K 0.15% 111
2019
Q2 		$459K Buy
7,257
+1,725
+31% +$87.4K 0.18% 101
2019
Q1 		$266K Buy
+5,532
New +$266K 0.11% 125
2018
Q4 		– Sell
-8,100
Closed -$424K – 147
2018
Q3 		$424K Buy
+8,100
New +$322K 0.17% 102

Other funds holding NVCR

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Schnieders Capital Management's NVCR Position: Q4 2021 in Review

Schnieders Capital Management sold out of NovoCure (NVCR) in Q4 2021, closing a stake of 2,757 shares — an estimated $320K sold.

Schnieders Capital Management first reported a position in NVCR in Q3 2018 and held it in 12 quarters. The position peaked at $793K in Q4 2020. 311 funds tracked by Wall St. Rank hold NVCR as of Q4 2021.

  • Schnieders Capital Management reported no remaining NovoCure position as of Q4 2021 after selling out during the quarter.
  • Schnieders Capital Management sold 2,757 NovoCure shares in Q4 2021, an estimated $320K.
  • Schnieders Capital Management first reported a position in NovoCure in Q3 2018 and held it in 12 quarters.
  • Schnieders Capital Management's NovoCure position peaked at $793K in Q4 2020.
  • 311 funds tracked by Wall St. Rank held NovoCure as of Q4 2021.

Based on Schnieders Capital Management's 13F filing for Q4 2021, filed 3 Feb 2022.